UKCapital Intelligence Plans
← Company directory

Series B

Genomics plc

Genomics / computational biology drug discovery

VerifiedSeries BOxford
Companies House
08839972
GLEIF LEI
Not matched
Latest evidence
2021-01-01
Evidence snapshot
2026-08-25
Funding signal1

Dated disclosed rounds · latest 2021-01-01

Procurement signal0

Exact award notices · latest No exact award match

Registry observationMatched

2026-08-01

Regional contextSouth East

Jun 2026

Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.

Evidence timeline

3 dated observations

Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.

  1. RegistryRecord observation

    Status observed: Active

    Snapshot evidence only; this row does not claim the status changed on this date.

  2. FundingSource fact

    Series B

    £33M total (£25M initial + £8M second close) · 1 named investor

  3. RegistryRegistry fact

    Company incorporated

    GENOMICS LIMITED · company 08839972

Latest disclosed round

Series B

Date
2021-01-01
Amount
GBP 33m
Sector
Biotech & techbio
Companies House
08839972
ONS region
South East

Evidence status

Directory ready

Identity
Verified
Match
High — exact company number and aligned registered name
Operating status
active
Data origins
Core directory, Growth Network, Live Chris T D1

Capital network

2 linked investors

Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.

Hambro PerksparticipantOxford Science Enterprisesparticipant
InvestorRoleDateSourceMatch / state
Hambro Perksparticipant2026-08-25Salicainvestments ↗reviewed canonical company and investor alias resolutionsource-linked · published
Oxford Science Enterprisesparticipant2026-08-25Oxfordscienceenterprises ↗reviewed canonical company and investor alias resolutionsource-linked · published

Funding record

1 disclosed round

Open a dated round to move directly between the company, named investors and source publication.

DateStageAmountInvestorsNamed sources
2021-01-01Series B£33M total (£25M initial + £8M second close)1 additional source-listed nameGenomics ↗ · Genomics ↗

Companies House status and filing snapshot

GENOMICS LIMITED

Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.

Registered record

Status
Active
Company type
Private Limited Company
Country of origin
United Kingdom
Incorporated
2014-01-10
Dissolved
Not applicable
Company number
08839972

Filing context

Accounts category
GROUP
Accounts made up to
2025-12-31
Next accounts due
2027-09-30
Confirmation made up to
2025-10-27
Registry snapshot
2026-08-01
Live check
Bulk snapshot only
72110Research and experimental development on biotechnology

SourceCompanies HouseDate2026-08-01Matchexact Companies House numberStatepublished projection

Companies House ↗Registry report →

Traceability

Source trail

Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.